Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online October 11, 2007
Stem Cells Vol. 26 No. 1 January 2008, pp. 3 -16
doi:10.1634/stemcells.2007-0194; www.StemCells.com
© 2008 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2007-0194v1
26/1/3    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serafimidis, I.
Right arrow Articles by Gavalas, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serafimidis, I.
Right arrow Articles by Gavalas, A.

EMBRYONIC STEM CELLS

Novel Effectors of Directed and Ngn3-Mediated Differentiation of Mouse Embryonic Stem Cells into Endocrine Pancreas Progenitors

Ioannis Serafimidisa, Irini Rakatzia, Vasso Episkopoub, Mina Goutia, Anthony Gavalasa

aDevelopmental Biology Laboratory, Biomedical Research Foundation of the Academy of Athens, Athens, Greece;
bMammalian Neurogenesis Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom

Key Words. Embryonic stem cells • Directed differentiation • Endocrine pancreas • Microarrays • Gene regulation • Signaling pathways

Correspondence: Correspondence: Anthony Gavalas, Ph.D., Biomedical Research Foundation of the Academy of Athens, Athens, Greece; Telephone: 0030-210-6597209; Fax: 0030-210-6597209; e-mail: agavalas{at}bioacademy.gr

Received on March 19, 2007; accepted for publication on September 28, 2007.

First published online in STEM CELLS EXPRESS  October 11, 2007.


The delineation of regulatory networks involved in early endocrine pancreas specification will play a crucial role in directing the differentiation of embryonic stem cells toward the mature phenotype of β cells for cell therapy of type 1 diabetes. The transcription factor Ngn3 is required for the specification of the endocrine lineage, but its direct targets and the scope of biological processes it regulates remain elusive. We show that stepwise differentiation of embryonic stem cells using successive in vivo patterning signals can lead to simultaneous induction of Ptf1a and Pdx1 expression. In this cellular context, Ngn3 induction results in upregulation of its known direct target genes within 12 hours. Microarray gene expression profiling at distinct time points following Ngn3 induction suggested novel and diverse roles of Ngn3 in pancreas endocrine cell specification. Induction of Ngn3 expression results in regulation of the Wnt, integrin, Notch, and transforming growth factor β signaling pathways and changes in biological processes affecting cell motility, adhesion, the cytoskeleton, the extracellular matrix, and gene expression. Furthermore, the combination of in vivo patterning signals and inducible Ngn3 expression enhances ESC differentiation toward the pancreas endocrine lineage. This is shown by strong upregulation of endocrine lineage terminal differentiation markers and strong expression of the hormones glucagon, somatostatin, and insulin. Importantly, all insulin+ cells are also C-peptide+, and glucose-dependent insulin release was 10-fold higher than basal levels. These data suggest that bona fide pancreas endocrine cells have been generated and that timely induction of Ngn3 expression can play a decisive role in directing ESC differentiation toward the endocrine lineage.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
M. D. Kinkel, E. M. Sefton, Y. Kikuchi, T. Mizoguchi, A. B. Ward, and V. E. Prince
Cyp26 enzymes function in endoderm to regulate pancreatic field size
PNAS, May 12, 2009; 106(19): 7864 - 7869.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Mimeault and S K Batra
Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer
Gut, October 1, 2008; 57(10): 1456 - 1468.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Gouti and A. Gavalas
Hoxb1 Controls Cell Fate Specification and Proliferative Capacity of Neural Stem and Progenitor Cells
Stem Cells, August 1, 2008; 26(8): 1985 - 1997.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2008 by AlphaMed Press.